Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Update

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the recipient of a large decline in short interest in the month of January. As of January 15th, there was short interest totaling 3,024 shares, a decline of 64.3% from the December 31st total of 8,463 shares. Based on an average daily trading volume, of 118,888 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily trading volume, of 118,888 shares, the days-to-cover ratio is presently 0.0 days.

Alpha Tau Medical Stock Performance

NASDAQ:DRTSW traded down $0.05 on Friday, reaching $0.91. 19,730 shares of the stock traded hands, compared to its average volume of 97,496. Alpha Tau Medical has a 1-year low of $0.13 and a 1-year high of $1.18. The company’s 50 day moving average is $0.51 and its 200-day moving average is $0.37.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.